For Immediate Release
Chicago, IL – March 21, 2022 – Zacks.com releases the list of companies likely to issue earnings surprises. This week’s list includes FedEx
FDX
, Oracle
ORCL
, Nike
NKE
, Darden Restaurants
DRI
and JPMorgan
JPM
.
A Cloudier Earnings Outlook
The March-quarter still has a couple of weeks left in it, but the 2022 Q1 earnings season has gotten underway already, with recent results from the likes of
FedEx
,
Oracle
, and 4 others getting counted as part of the official March-quarter tally. We have another 7 S&P 500 members on deck to report results in the coming week, including
Nike
,
Darden Restaurants
and others.
All of these reports are for their fiscal quarters ending in February, which we count as part of our March-quarter tally.
JPMorgan
and the other big banks will spearhead the March-quarter reporting cycle on April 13th.
The geopolitical uncertainty in the wake of the Ukraine situation adds to the market’s existing worries about inflation and supply-chain challenges that have been recurring themes in recent months. The addition of geopolitical tensions to the mix has direct implications for the inflation outlook through higher prices for energy and other commodities. All of that has a bearing on the earnings outlook.
We knew all along that earnings growth was expected to decelerate significantly in the current and coming quarters, after remaining very strong in the preceding periods. But the outlook for earnings had started easing even before the recent geopolitical developments. We saw this in the revisions trend, which had been mixed at best.
The expectation currently is for 2022 Q1 estimates to be up +3.8% from the same period last year on +10.1% higher revenues. In other words, current bottom-up estimates reflect compression in margins, which is in-line with the aforementioned inflationary trends.
Revisions to the 2022 Q1 estimates are mixed, with estimates for 9 of the 16 Zacks sectors going down since the start of January, with the Consumer Discretionary, Transportation and Aerospace sectors suffering significant estimate cuts. In fact, Q1 estimates for the Transportation sector are down by more than a third since the start of the quarter, and Consumer Discretionary estimates have been cut more than 25%.
Offsetting the estimate cuts are positive revisions to other sectors, with the Energy sector enjoying the most positive revisions. Other sectors seeing positive estimate revisions include Medical, Autos and Construction.
In the aggregate, 2022 Q1 estimates for the S&P 500 index are up +0.3% since the start of the quarter. However, if we look at the revisions trend on an ex-Energy basis, Q1 estimates for the rest of the 15 sectors are down -0.9% since the start of the quarter.
For full-year 2022, the expectation is for earnings growth of +7.2% on +6.4% revenue growth. This would follow the +49.9% earnings growth in 2021.
Full-year 2022 earnings estimates have modestly inched up since the start of the year, with total S&P 500 earnings up +1.4% since the start of January. There are a lot of cross-currents at the sector level, with estimates going down for 9 of the 16 Zacks sectors and going up for the rest. In fact, it is the positive revisions to the Energy sector that are offsetting the estimate cuts in the aggregate.
Excluding the positive revisions to the Energy sector, total S&P 500 earnings for 2022 would be down -11.9% since the start of January. The biggest declines have been for the Consumer Discretionary, Transportation and Utilities sectors.
Q1 margins are expected to be the lowest since 2020 Q4. But current estimates for Q2 and beyond reflect some improvement in margins. It is this margins outlook that is most likely at risk of weakening in the coming days, given the darkening clouds on the horizon.
For Q1, margins are expected to be below the year-earlier level for 9 of the 16 Zacks sectors, with strong margin gains for three sectors (Energy, Transportation and Basic Materials).
The growth picture has shifted materially for the Finance and Technology sectors, the two biggest earnings contributors to the index. Total Finance sector earnings are expected to be down -17.8% from the same period last year on +2.4% higher revenues, while Tech sector earnings are expected to be down -0.9% in Q1 on +7.3% higher revenues.
The 2022 Q1 Earnings Season Scorecard
The Q1 earnings season will really get going with the big banks reporting March-quarter results in mid-April, but the early reports have come out already. As mentioned earlier, the recent quarterly reports from FedEx, Oracle and four others for their respective fiscal quarters ending in February qualify as the early Q1 reports.
We will have seen such Q1 results from almost two dozen S&P 500 members by the time JPMorgan comes out with quarterly results on April 13th.
For the 6 index members that have reported Q1 results already, total earnings are up +9.6% from the same period last year on +14.5% higher revenues, with 66.7% beating EPS estimates and all of them beating revenue estimates.
For a detailed look at the overall earnings picture, including expectations for the coming periods, please check out our weekly
Earnings Trends
report >>>>
Pressure on Earnings Estimates: What Sectors Are Most Affected?
Why Haven’t You Looked at Zacks’ Top Stocks?
Our 5 best-performing strategies have blown away the S&P’s impressive +28.8% gain in 2021. Amazingly, they soared
+40.3%, +48.2%, +67.6%, +94.4%,
and
+95.3%
. Today you can access their live picks without cost or obligation.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks “Terms and Conditions of Service” disclaimer.
www.zacks.com/disclaimer
.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit
https://www.zacks.com/performance
for information about the performance numbers displayed in this press release.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.
See these 7 breakthrough stocks now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report
